Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1990-12-12
|
pubmed:abstractText |
The influence of recombinant human interleukins-1 beta and -1 alpha and rat interleukin-1 beta on gastric acid secretion was investigated in awake rats with pylorus ligation. IC injection of either human interleukin-1 beta, human interleukin-1 alpha, or rat interleukin-1 beta induced a dose-dependent inhibition of gastric acid output. At IC doses less than 100 ng, human interleukin-1 beta was more effective than the other forms or sources of interleukin-1, whereas at higher doses (100-500 ng), human interleukins-1 beta and -1 alpha and rat interleukin-1 beta were equipotent. The inhibitory effect was observed 30 minutes after interleukin-1 injection and maintained throughout the 6-hour experimental period. IC injection of interleukin-1 beta inhibited vagally stimulated gastric acid secretion induced by IC injection of the stable thyrotropin-releasing hormone analogue RX 77368. Indomethacin (1, 5, and 10 mg/kg, IP, -30 minutes) induced a dose-related prevention of the inhibitory effect of IC interleukin-1 beta. IC injection of the corticotropin-releasing factor antagonist alpha-CRF9-41, bilateral adrenalectomy, and noradrenergic blockade with bretylium did not influence the antisecretory effect of interleukin-1. Polypeptide action was not related to changes in circulating gastrin levels. Human interleukin-1 beta injected IV also inhibited gastric acid secretion, but the peripheral dose required to induce a significant effect was 10(3)-fold higher than when given centrally. These results show that IC interleukin-1 beta acts centrally to induce a long-lasting inhibition of gastric acid secretion, and this effect requires the integrity of prostaglandin pathways. These data suggest a possible interaction between the immune and gastrointestinal systems.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Indomethacin,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/L-pyroglutamyl-L-histidyl-3,3-dimeth...,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrrolidonecarboxylic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Thyrotropin-Releasing Hormone
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0016-5085
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
99
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1599-606
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2121579-Animals,
pubmed-meshheading:2121579-Brain,
pubmed-meshheading:2121579-Dose-Response Relationship, Drug,
pubmed-meshheading:2121579-Gastric Acid,
pubmed-meshheading:2121579-Indomethacin,
pubmed-meshheading:2121579-Injections,
pubmed-meshheading:2121579-Injections, Intraperitoneal,
pubmed-meshheading:2121579-Interleukin-1,
pubmed-meshheading:2121579-Male,
pubmed-meshheading:2121579-Pyrrolidonecarboxylic Acid,
pubmed-meshheading:2121579-Rats,
pubmed-meshheading:2121579-Rats, Inbred Strains,
pubmed-meshheading:2121579-Recombinant Proteins,
pubmed-meshheading:2121579-Thyrotropin-Releasing Hormone
|
pubmed:year |
1990
|
pubmed:articleTitle |
Central action of recombinant interleukin-1 to inhibit acid secretion in rats.
|
pubmed:affiliation |
Center for Ulcer Research and Education, VA Wadsworth Medical Center, Los Angeles.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|